{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T20:41:46Z","timestamp":1794861706508,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":217,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Aging Research &amp; Lifestyle"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.jarlif.2026.100083","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:34:27Z","timestamp":1786725267000},"page":"100083","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["GLP-1 receptor agonist therapy and skeletal muscle: A narrative review synthesizing adult evidence with implications for older adults"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6108-2942","authenticated-orcid":false,"given":"Krish","family":"Jagasia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9633-1928","authenticated-orcid":false,"given":"Kenneth","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.jarlif.2026.100083_bib0001","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1001\/jama.2025.14392","article-title":"New molecules and indications for GLP-1 medicines","volume":"334","author":"Gonzalez-Rellan","year":"2025","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.jarlif.2026.100083_bib0002","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.2337\/dci24-0003","article-title":"Efficacy and safety of GLP-1 medicines for type 2 diabetes and obesity","volume":"47","author":"Drucker","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jarlif.2026.100083_bib0003","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/jama.2025.24288","article-title":"World Health Organization guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults","volume":"335","author":"Celletti","year":"2025","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0004","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s40520-025-03021-8","article-title":"Aging, longevity, and healthy aging: the public health approach","volume":"37","author":"Gianfredi","year":"2025","journal-title":"Aging Clin Exp Res"},{"issue":"10","key":"10.1016\/j.jarlif.2026.100083_bib0005","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.2023.15231","article-title":"Sedentary behavior and incident dementia among older adults","volume":"330","author":"Raichlen","year":"2023","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0006","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1186\/s12889-025-23793-y","article-title":"Exploring the perceptions of sedentary behaviour in community-dwelling older adults aged 75 and older: a series of focus group interviews","volume":"25","author":"Tadrous","year":"2025","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jarlif.2026.100083_bib0007","doi-asserted-by":"crossref","unstructured":"Emmerich SD, D.V.M., Fryar CD, et al. Products - data briefs - number 508 September 2024. October 9, 2024. doi:10.15620\/cdc\/159281.","DOI":"10.15620\/cdc\/159281"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0008","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"10","key":"10.1016\/j.jarlif.2026.100083_bib0009","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.2337\/dc21-0455","article-title":"Replacement of sedentary behavior by various daily-life physical activities and structured exercises: genetic risk and incident type 2 diabetes","volume":"44","author":"Li","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jarlif.2026.100083_bib0010","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.clnesp.2022.06.001","article-title":"Sedentary behavior, physical inactivity, abdominal obesity and obesity in adults and older adults: a systematic review and meta-analysis","volume":"50","author":"Silveira","year":"2022","journal-title":"Clin Nutr ESPEN"},{"issue":"8","key":"10.1016\/j.jarlif.2026.100083_bib0011","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0012","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an Endocrine Society* clinical practice guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"10.1016\/j.jarlif.2026.100083_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.jamda.2025.105724","article-title":"Pattern of antidiabetic drug prescription in older persons with type 2 diabetes: results from the German DPV registry","volume":"26","author":"Zeyfang","year":"2025","journal-title":"J Am Med Dir Assoc"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0014","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1001\/jamainternmed.2025.1794","article-title":"Integrating diet and physical activity when prescribing GLP-1s\u2014Lifestyle factors remain crucial","volume":"185","author":"Mehrtash","year":"2025","journal-title":"JAMA Intern Med"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0015","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s13668-025-00649-w","article-title":"Impact of GLP- 1 receptor agonist therapy in patients high risk for sarcopenia","volume":"14","author":"Memel","year":"2025","journal-title":"Curr Nutr Rep"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0016","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1038\/s41467-025-59485-9","article-title":"GDF8 and activin A blockade protects against GLP-1\u2013induced muscle loss while enhancing fat loss in obese male mice and non-human primates","volume":"16","author":"Mastaitis","year":"2025","journal-title":"Nat Commun"},{"issue":"2","key":"10.1016\/j.jarlif.2026.100083_bib0017","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000549808","article-title":"Prevalence and factors associated with sarcopenia in community-dwelling older adults: a systematic review and meta-analysis","volume":"72","author":"Wang","year":"2026","journal-title":"Gerontology"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0018","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1210\/clinem\/dgab884","article-title":"Prevalence and risk factors of sarcopenia in patients with diabetes: a meta-analysis","volume":"107","author":"Feng","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0019","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0233299","article-title":"The prevalence and factors associated with sarcopenia among community living elderly with type 2 diabetes mellitus in primary care clinics in Malaysia","volume":"15","author":"Sazlina","year":"2020","journal-title":"Plos One"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0326193","article-title":"Association between sarcopenia and falls in Chinese older adults: findings from the China health and retirement longitudinal study","volume":"20","author":"Yang","year":"2025","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.jarlif.2026.100083_bib0021","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/jcsm.12411","article-title":"Sarcopenia and its association with falls and fractures in older adults: a systematic review and meta-analysis","volume":"10","author":"Yeung","year":"2019","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.jarlif.2026.100083_bib0022","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2147\/CIA.S150067","article-title":"Quality of life and psychological consequences in elderly patients after a hip fracture: a review","volume":"Volume 13","author":"Alexiou","year":"2018","journal-title":"Clin Interv Aging"},{"issue":"22","key":"10.1016\/j.jarlif.2026.100083_bib0023","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1161\/01.cir.0000436752.99896.22","article-title":"Secondary prevention of atherosclerotic cardiovascular disease in older adults","volume":"128","author":"Fleg","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0024","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/jgs.70187","article-title":"GLP-1 receptor agonist therapy and cardiorenal outcomes in patients \u2265 80 years old with type 2 diabetes","volume":"74","author":"Chen","year":"2026","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jarlif.2026.100083_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2025.105981","article-title":"Efficacy of GLP-1 receptor agonists among older adults: a meta-analysis of cardio-kidney outcome trials","volume":"138","author":"Waqas","year":"2025","journal-title":"Arch Gerontol Geriatr"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0026","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","article-title":"Prevalence and impact of polypharmacy in older patients with type 2 diabetes","volume":"34","author":"Remelli","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.jarlif.2026.100083_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1284287","article-title":"Associated adverse health outcomes of polypharmacy and potentially inappropriate medications in community-dwelling older adults with diabetes","volume":"14","author":"Lu","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jarlif.2026.100083_bib0028","doi-asserted-by":"crossref","first-page":"996","DOI":"10.7326\/ANNALS-25-00478","article-title":"Effect of incretin-based and nonpharmacologic weight loss on body composition","volume":"179","author":"Batsis","year":"2026","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jarlif.2026.100083_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2019.00861","article-title":"Aging and imaging assessment of body composition: from fat to facts","volume":"10","author":"Ponti","year":"2020","journal-title":"Front Endocrinol"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1093\/ageing\/afy169","article-title":"Sarcopenia: revised European consensus on definition and diagnosis","volume":"48","author":"Cruz-Jentoft","year":"2019","journal-title":"Age Ageing"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0031","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2010.1923","article-title":"Gait speed and survival in older adults","volume":"305","author":"Studenski","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.jarlif.2026.100083_bib0032","article-title":"Understanding impact of anti-obesity medications on skeletal muscle mass change is confounded by measurement methods","volume":"27","author":"McMath","year":"2026","journal-title":"Obes Rev. n\/a(n\/a)"},{"issue":"2","key":"10.1016\/j.jarlif.2026.100083_bib0033","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41430-018-0335-3","article-title":"Bioelectrical impedance analysis for body composition assessment: reflections on accuracy, clinical utility, and standardisation","volume":"73","author":"Ward","year":"2019","journal-title":"Eur J Clin Nutr"},{"issue":"3","key":"10.1016\/j.jarlif.2026.100083_bib0034","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/dom.16162","article-title":"Weight loss and body composition after compounded semaglutide treatment in a real world setting","volume":"27","author":"Chun","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"20","key":"10.1016\/j.jarlif.2026.100083_bib0035","first-page":"9908","article-title":"Clinical effectiveness of semaglutide on weight loss, body composition, and muscle strength in Chinese adults","volume":"27","author":"Xiang","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"21","key":"10.1016\/j.jarlif.2026.100083_bib0036","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.3390\/nu14214673","article-title":"Once-weekly subcutaneous semaglutide improves fatty liver disease in patients with type 2 diabetes: a 52-week prospective real-life study","volume":"14","author":"Volpe","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0037","doi-asserted-by":"crossref","first-page":"47","DOI":"10.3390\/medicines9090047","article-title":"The effectiveness of GLP-1 receptor agonist semaglutide on body composition in elderly obese diabetic patients: a pilot study","volume":"9","author":"Ozeki","year":"2022","journal-title":"Medicines"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0038","first-page":"1003","article-title":"[Changes in weight, body composition, metabolic parameters and vitamin D in subjects with grade 3 and 4 obesity treated with liraglutide 3 mg]","volume":"41","author":"Blanco Anesto","year":"2024","journal-title":"Nutr Hosp"},{"issue":"18","key":"10.1016\/j.jarlif.2026.100083_bib0039","first-page":"6813","article-title":"Comparison of the effect of liraglutide and metformin therapy on the disease regulation and weight loss in obese patients with type 2 diabetes mellitus","volume":"26","author":"Keskin","year":"2022","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"10","key":"10.1016\/j.jarlif.2026.100083_bib0040","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1007\/s00125-025-06493-5","article-title":"Early induction of insulin sensitisation treated by tirzepatide: a prospective, single-arm, open-label study in Japanese individuals with obesity and type 2 diabetes","volume":"68","author":"Yamaguchi","year":"2025","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.jarlif.2026.100083_bib0041","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/cid\/ciae384","article-title":"Effects of semaglutide on muscle structure and function in the SLIM LIVER study","volume":"80","author":"Ditzenberger","year":"2025","journal-title":"Clin Infect Dis"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0042","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.24.31805","article-title":"Intrapatient changes in CT-based body composition after initiation of semaglutide (Glucagon-Like Peptide-1 Receptor Agonist) therapy","volume":"223","author":"Nelson","year":"2024","journal-title":"Am J Roentgenol"},{"key":"10.1016\/j.jarlif.2026.100083_bib0043","article-title":"Nutritional deficiencies and muscle loss in adults with type 2 diabetes using GLP-1 receptor agonists: a retrospective observational study","volume":"15","author":"Scott Butsch","year":"2025","journal-title":"Obes Pillars"},{"issue":"12","key":"10.1016\/j.jarlif.2026.100083_bib0044","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.3390\/nu14122414","article-title":"Once-weekly semaglutide induces an early improvement in body composition in patients with type 2 diabetes: a 26-week prospective real-life study","volume":"14","author":"Volpe","year":"2022","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0045","doi-asserted-by":"crossref","first-page":"5042","DOI":"10.1111\/dom.16552","article-title":"Glucagon-like peptide-1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity","volume":"27","author":"Wang","year":"2025","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"10.1016\/j.jarlif.2026.100083_bib0046","doi-asserted-by":"crossref","first-page":"377","DOI":"10.14740\/jocmr4987","article-title":"Oral semaglutide induces loss of body fat mass without affecting muscle mass in patients with type 2 diabetes","volume":"15","author":"Uchiyama","year":"2023","journal-title":"J Clin Med Res"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0047","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-8587(25)00027-0","article-title":"Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"3","key":"10.1016\/j.jarlif.2026.100083_bib0048","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1002\/jcsm.13445","article-title":"Effect of liraglutide on thigh muscle fat and muscle composition in adults with overweight or obesity: results from a randomized clinical trial","volume":"15","author":"Pandey","year":"2024","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"23","key":"10.1016\/j.jarlif.2026.100083_bib0049","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000038444","article-title":"Favorable liver and skeletal muscle changes in patients with MASLD and T2DM receiving glucagon-like peptide-1 receptor agonist: a prospective cohort study","volume":"103","author":"Kakegawa","year":"2024","journal-title":"Medicine"},{"issue":"12","key":"10.1016\/j.jarlif.2026.100083_bib0050","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jarlif.2026.100083_bib0051","doi-asserted-by":"crossref","first-page":"5645","DOI":"10.2147\/DDDT.S531778","article-title":"Semaglutide therapy and accelerated sarcopenia in older adults with type 2 diabetes: a 24-month retrospective cohort study","volume":"Volume 19","author":"Ren","year":"2025","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/j.jarlif.2026.100083_bib0052","doi-asserted-by":"crossref","DOI":"10.1177\/11795514231161885","article-title":"Favorable appendicular skeletal muscle mass changes in older patients with type 2 diabetes receiving GLP-1 receptor agonist and Basal insulin Co-therapy","volume":"16","author":"Osaka","year":"2023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"issue":"4","key":"10.1016\/j.jarlif.2026.100083_bib0053","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1210\/clinem\/dgac613","article-title":"Effects of GLP-1 infusion upon whole-body glucose uptake and skeletal muscle perfusion during fed-state in older men","volume":"108","author":"Abdulla","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0054","doi-asserted-by":"crossref","DOI":"10.1111\/acel.13202","article-title":"Glucagon-like peptide 1 infusions overcome anabolic resistance to feeding in older human muscle","volume":"19","author":"Abdulla","year":"2020","journal-title":"Aging Cell"},{"issue":"8","key":"10.1016\/j.jarlif.2026.100083_bib0055","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0056","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/ageing\/afaa123","article-title":"The clinical usefulness of muscle mass and strength measures in older people: a systematic review","volume":"50","author":"Lunt","year":"2021","journal-title":"Age Ageing"},{"issue":"3","key":"10.1016\/j.jarlif.2026.100083_bib0057","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol Ser A"},{"issue":"20","key":"10.1016\/j.jarlif.2026.100083_bib0058","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1056\/NEJMoa1616338","article-title":"Aerobic or resistance exercise, or both, in dieting obese older adults","volume":"376","author":"Villareal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jarlif.2026.100083_bib0059","doi-asserted-by":"crossref","DOI":"10.1111\/bph.70355","article-title":"Glucagon-like peptide-1 receptor agonists and muscle strength changes in older adults: risks beyond muscle mass reductions","author":"Prokopidis","year":"2026","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jarlif.2026.100083_bib0060","doi-asserted-by":"crossref","first-page":"k1651","DOI":"10.1136\/bmj.k1651","article-title":"Associations of grip strength with cardiovascular, respiratory, and cancer outcomes and all cause mortality: prospective cohort study of half a million UK Biobank participants","volume":"361","author":"Celis-Morales","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jarlif.2026.100083_bib0061","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101778","article-title":"Thresholds of handgrip strength for all-cause, cancer, and cardiovascular mortality: a systematic review with dose-response meta-analysis","volume":"82","author":"L\u00f3pez-Bueno","year":"2022","journal-title":"Ageing Res Rev"},{"issue":"9990","key":"10.1016\/j.jarlif.2026.100083_bib0062","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/S0140-6736(14)62000-6","article-title":"Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study","volume":"386","author":"Leong","year":"2015","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/j.jarlif.2026.100083_bib0063","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1249\/MSS.0000000000001683","article-title":"Handgrip strength, function, and mortality in older adults: a time-varying approach","volume":"50","author":"Mcgrath","year":"2018","journal-title":"Med Sci Sports Exerc"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0064","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/jgs.12840","article-title":"Muscle strength and physical performance as predictors of mortality, hospitalization, and disability in the oldest old","volume":"62","author":"Legrand","year":"2014","journal-title":"J Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.jarlif.2026.100083_bib0065","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1210\/clinem\/dgaf335","article-title":"Incretin receptor agonism, fat-free mass, and cardiorespiratory fitness: a narrative review","volume":"110","author":"Liu","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.jarlif.2026.100083_bib0066","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/jcsm.12913","article-title":"Population-based cohort imaging: skeletal muscle mass by magnetic resonance imaging in correlation to bioelectrical-impedance analysis","volume":"13","author":"Kiefer","year":"2022","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0067","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1002\/jpen.2366","article-title":"Guidance for assessment of the muscle mass phenotypic criterion for the Global Leadership Initiative on Malnutrition diagnosis of malnutrition","volume":"46","author":"Compher","year":"2022","journal-title":"J Parenter Enter Nutr"},{"issue":"11\u201312","key":"10.1016\/j.jarlif.2026.100083_bib0068","first-page":"749","article-title":"Bioelectrical impedance analysis in body composition measurement. National Institutes of Health Technology Assessment Conference Statement. December 12-14, 1994","volume":"12","year":"1996","journal-title":"Nutrition"},{"issue":"39","key":"10.1016\/j.jarlif.2026.100083_bib0069","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000035250","article-title":"Comparison between bioelectrical impedance analyses and dual-energy X-ray absorptiometry for accuracy in assessing appendicular skeletal muscle mass and diagnosing sarcopenia in hospitalized Chinese older adults","volume":"102","author":"Liu","year":"2023","journal-title":"Medicine"},{"issue":"7","key":"10.1016\/j.jarlif.2026.100083_bib0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0200465","article-title":"Comparison of body composition assessment by DXA and BIA according to the body mass index: a retrospective study on 3655 measures","volume":"13","author":"Achamrah","year":"2018","journal-title":"PloS One"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0071","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/ejcn.2017.27","article-title":"Quantification of whole-body and segmental skeletal muscle mass using phase-sensitive 8-electrode medical bioelectrical impedance devices","volume":"71","author":"Bosy-Westphal","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/j.jarlif.2026.100083_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2026.103991","article-title":"Balancing the benefits and risks of GLP-1 receptor agonists: a clinical guide for shared decision-making","volume":"96","author":"Moiz","year":"2026","journal-title":"eClinicalMedicine"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0073","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1053\/j.gastro.2022.08.045","article-title":"AGA clinical practice guideline on pharmacological interventions for adults with obesity","volume":"163","author":"Grunvald","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jarlif.2026.100083_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2024.156113","article-title":"Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis","volume":"164","author":"Karakasis","year":"2025","journal-title":"Metabolism"},{"issue":"Suppl 1","key":"10.1016\/j.jarlif.2026.100083_bib0075","first-page":"S277","article-title":"Standards of care in diabetes\u20142026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.jarlif.2026.100083_bib0076","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1001\/jama.2025.11153","article-title":"Managing adverse effects of incretin-based medications for obesity","volume":"334","author":"Kushner","year":"2025","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jarlif.2026.100083_bib0077","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13916","article-title":"How do glucagon-like peptide-1 receptor agonists affect measures of muscle mass in individuals with, and without, type 2 diabetes: a systematic review and meta-analysis","volume":"26","author":"Anyiam","year":"2025","journal-title":"Obes Rev Off J Int Assoc Study Obes"},{"key":"10.1016\/j.jarlif.2026.100083_bib0078","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.clnu.2025.10.006","article-title":"Glucagon-like peptide-1 receptor agonists and sarcopenia-related markers in diabetes: a systematic review and meta-analysis","volume":"55","author":"Chen","year":"2025","journal-title":"Clin Nutr"},{"issue":"4","key":"10.1016\/j.jarlif.2026.100083_bib0079","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/nu18040632","article-title":"A narrative review on GLP-1 receptor agonists for obesity in older women: maximizing weight loss while preserving lean mass","volume":"18","author":"Moscucci","year":"2026","journal-title":"Nutrients"},{"issue":"3","key":"10.1016\/j.jarlif.2026.100083_bib0080","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70063","article-title":"Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: a systematic review and meta-analysis","volume":"17","author":"Yang","year":"2025","journal-title":"J Diabetes"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0081","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1097\/GME.0000000000001509","article-title":"The association between hormone therapy and sarcopenia in postmenopausal women: the Korea National Health and Nutrition Examination Survey, 2008-2011","volume":"27","author":"Kim","year":"2020","journal-title":"Menopause"},{"key":"10.1016\/j.jarlif.2026.100083_bib0082","doi-asserted-by":"crossref","DOI":"10.1016\/j.maturitas.2025.108609","article-title":"Systematic review on the relationship between menopausal hormone replacement therapy, sarcopenia, and sarcopenia-related parameters","volume":"199","author":"\u00d6sterdahl","year":"2025","journal-title":"Maturitas"},{"issue":"8","key":"10.1016\/j.jarlif.2026.100083_bib0083","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.10154","article-title":"Association between hormone therapy and muscle mass in postmenopausal women: a systematic review and meta-analysis","volume":"2","author":"Javed","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"S1","key":"10.1016\/j.jarlif.2026.100083_bib0084","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/oby.24229","article-title":"The impact of lifestyle-based weight loss in older adults with obesity on muscle and bone health: a balancing act","volume":"33","author":"Cortes","year":"2025","journal-title":"Obesity"},{"issue":"Supplement_1","key":"10.1016\/j.jarlif.2026.100083_bib0085","doi-asserted-by":"crossref","first-page":"S277","DOI":"10.2337\/dc26-S013","article-title":"Older adults: standards of care in diabetes\u20142026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jarlif.2026.100083_bib0086","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2147\/CIA.S194543","article-title":"Grip strength: an indispensable biomarker for older adults","volume":"Volume 14","author":"Bohannon","year":"2019","journal-title":"Clin Interv Aging"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0087","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1519\/JPT.0000000000000224","article-title":"Assessment of gait speed in older adults","volume":"43","author":"Mehmet","year":"2020","journal-title":"J Geriatr Phys Ther"},{"key":"10.1016\/j.jarlif.2026.100083_bib0088","doi-asserted-by":"crossref","DOI":"10.1016\/j.archger.2025.106026","article-title":"Normative reference values for the six-minute walk test in older adults: a systematic review and meta-analysis","volume":"140","author":"Otadi","year":"2026","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.jarlif.2026.100083_bib0089","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112924","article-title":"GLP-1 receptor agonists and sarcopenia: weight loss at a cost? A brief narrative review","volume":"229","author":"Pantazopoulos","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"10.1016\/j.jarlif.2026.100083_bib0090","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1093\/ejendo\/lvaf223","article-title":"Glucagon-like peptide-1 receptor agonists and muscle health: potential role in sarcopenia prevention and treatment","volume":"193","author":"Gonz\u00e1lez-Luis","year":"2025","journal-title":"Eur J Endocrinol"},{"issue":"8","key":"10.1016\/j.jarlif.2026.100083_bib0091","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0092","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clnu.2014.04.007","article-title":"Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group","volume":"33","author":"Deutz","year":"2014","journal-title":"Clin Nutr"},{"issue":"2","key":"10.1016\/j.jarlif.2026.100083_bib0093","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/ajcn\/nqaa323","article-title":"Dietary leucine requirement of older men and women is higher than current recommendations","volume":"113","author":"Szwiega","year":"2021","journal-title":"Am J Clin Nutr"},{"issue":"12","key":"10.1016\/j.jarlif.2026.100083_bib0094","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.3390\/nu11122861","article-title":"Vitamin D deficiency and sarcopenia in older persons","volume":"11","author":"Remelli","year":"2019","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12020-022-03208-3","article-title":"Vitamin D in the older population: a consensus statement","volume":"79","author":"Giustina","year":"2023","journal-title":"Endocrine"},{"issue":"4","key":"10.1016\/j.jarlif.2026.100083_bib0096","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s40279-023-01983-1","article-title":"Exercise snacks and other forms of intermittent physical activity for improving health in adults and older adults: a scoping review of epidemiological, experimental and qualitative studies","volume":"54","author":"Jones","year":"2024","journal-title":"Sports Med"},{"key":"10.1016\/j.jarlif.2026.100083_bib0097","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155597","article-title":"Current and investigational medications for the treatment of sarcopenia","volume":"149","author":"Rolland","year":"2023","journal-title":"Metabolism"},{"issue":"18","key":"10.1016\/j.jarlif.2026.100083_bib0098","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2022.37.e146","article-title":"A review of sarcopenia pathophysiology, diagnosis, treatment and future direction","volume":"37","author":"Cho","year":"2022","journal-title":"J Korean Med Sci"},{"issue":"4","key":"10.1016\/j.jarlif.2026.100083_bib0099","doi-asserted-by":"crossref","first-page":"e287","DOI":"10.1016\/S2666-7568(24)00007-2","article-title":"Prevalence of multimorbidity and polypharmacy among adults and older adults: a systematic review","volume":"5","author":"Nicholson","year":"2024","journal-title":"Lancet Healthy Longev"},{"issue":"0","key":"10.1016\/j.jarlif.2026.100083_bib0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14740338.2026.2640982","article-title":"GLP-1 receptor agonists in older people with type 2 diabetes: safety evidence from the real world","volume":"0","author":"Marassi","year":"2026","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.jarlif.2026.100083_bib0101","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1111\/jgs.13442","article-title":"Decline in fast gait speed as a predictor of disability in older adults","volume":"63","author":"Artaud","year":"2015","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0102","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12877-023-03890-6","article-title":"Change in gait speed and fall risk among community-dwelling older adults with and without mild cognitive impairment: a retrospective cohort analysis","volume":"23","author":"Adam","year":"2023","journal-title":"BMC Geriatr"},{"issue":"1","key":"10.1016\/j.jarlif.2026.100083_bib0103","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/jcsm.13160","article-title":"Recent sarcopenia definitions\u2014Prevalence, agreement and mortality associations among men: findings from population-based cohorts","volume":"14","author":"Westbury","year":"2023","journal-title":"J Cachexia Sarcopenia Muscle"}],"container-title":["The Journal of Aging Research &amp; Lifestyle"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X2600025X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2534773X2600025X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T19:35:51Z","timestamp":1786736151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2534773X2600025X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":103,"alternative-id":["S2534773X2600025X"],"URL":"https:\/\/doi.org\/10.1016\/j.jarlif.2026.100083","relation":{},"ISSN":["2534-773X"],"issn-type":[{"value":"2534-773X","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonist therapy and skeletal muscle: A narrative review synthesizing adult evidence with implications for older adults","name":"articletitle","label":"Article Title"},{"value":"The Journal of Aging Research & Lifestyle","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jarlif.2026.100083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Masson SAS on behalf of SERDI Publisher.","name":"copyright","label":"Copyright"}],"article-number":"100083"}}